Login / Signup

Reader Response: Investigating the Prevalence of Comorbidity in Multiple Sclerosis Clinical Trial Populations.

Lauren GroboisMichelle YouMill Etienne
Published in: Neurology (2024)
Keyphrases
  • multiple sclerosis
  • clinical trial
  • risk factors
  • phase ii
  • study protocol
  • open label
  • double blind
  • phase iii
  • randomized controlled trial
  • genetic diversity